Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
1864
-
Total shares
-
1.29B
-
Shares change
-
+40.1M
-
Total reported value, excl. options
-
$94.8B
-
Value change
-
+$2.99B
-
Put/Call ratio
-
0.68
-
Number of buys
-
785
-
Number of sells
-
-829
-
Price
-
$73.36
Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q3 2018
1,896 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q3 2018.
ABBOTT LABORATORIES - COM (ABT) has 1,864 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.29B shares
.
Largest 10 shareholders include Vanguard Group Inc (139M shares), Capital Research Global Investors (125M shares), BlackRock Inc. (117M shares), STATE STREET CORP (70.1M shares), WELLINGTON MANAGEMENT GROUP LLP (41.4M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (38.6M shares), Bank of New York Mellon Corp (27.2M shares), NORTHERN TRUST CORP (25.9M shares), MORGAN STANLEY (22.8M shares), and WELLS FARGO & COMPANY/MN (20.9M shares).
This table shows the top 1864 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.